The pharmaceutical sector in India presents a complex landscape, increasingly marked by concerns surrounding dominance . While the nation boasts a vibrant generic sector , a few major companies maintain a disproportionate share of the market , sparking questions about competition and consumer access to affordable treatments. This circumstance is fu

The drug landscape in this country is increasingly characterized by a pattern toward market dominance, with a handful of prominent companies wielding significant influence. These sector giants, often bolstered by long-standing distribution networks and robust brand recognition, present a difficult picture for competition and budget-friendly healthc

The Indian pharmaceutical industry, known for its affordable and accessible medicines, faces rising concerns about monopolies. A few dominant firms control a significant portion of the market, potentially limiting competition and driving up prices for consumers. This concern raises questions about the long-term impact on patient access to affordab